Trial design and protocol of randomized controlled trial comparing the efficacy of oral mefenamic acid, paracetamol and placebo for analgesic prophylaxis in childhood vaccination (MAP VaC trial)
Background: Needle related pain has been one of the most important concerns for parents of children receiving vaccination. Non-steroidal anti-inflammatory drugs (NSAIDs) like paracetamol and mefenamic acid have been commonly used as analgesics in pediatric population. However, prophylactic administration of these drugs for analgesia during vaccination has not been studied. The main objective of this study is to compare the efficacy of prophylactic paracetamol, mefenamic acid and placebo on needle pain associated with vaccination.
Methods: This is a three-arm parallel, triple blind, randomized controlled trial. Children aged 6 weeks to 7 years who need immunization as per national immunization schedule and reporting to pediatric outpatient department (OPD) at tertiary level hospital, AIIMS Mangalagiri, Andhra Pradesh, will be included. All participants will be randomly allotted to any of the three groups by computer based block randomization. Each participant will be given any one of the three drugs as per their allocation. Vaccination will be done as per national immunization schedule after 30 minutes of drug administration. Face, legs, activity, cry, consolability (FLACC) scoring will be done immediately after vaccine administration and repeated at 15 minutes and 30 minutes. All personnel involved in randomization, drug and vaccine administration, FLACC scoring and statistical analysis will be blinded along with parents and children enrolled in the study.
Conclusions: If this intervention study shows evidence of a difference between drug and placebo signifying reduction in vaccine related pain with these drugs, this will have a huge impact on National Immunization programme by improving compliance, vaccine coverage and by reducing vaccine hesitancy.
Trial registration: Clinical trials registration number is CTRI/2021/01/030239.
Morton NS. Pain assessment in children. Paediatr Anaesth. 1997;7(4):267-72.
McGrath PJ, Frager G. Psychological barriers to optimal pain management in infants and children. Clin J Pain. 1996;12(2):135-41.
Srouji R, Ratnapalan S, Schneeweiss S. Pain in Children: Assessment and Nonpharmacological Management. Int J Pediatr. 2010;474838.
Moore RA, Edwards J, Barden J, McQuay HJ. Bandolier's LittleBook of Pain. Oxford: Oxford University Press, 2003.
FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001;345(6):433-42.
Moll R, Derry S, Moore RA, McQuay HJ. Single dose oral mefenamic acid for acute postoperative pain in adults. Cochrane Database of Systematic Rev. 2011;3:CD007553.
Lee JJ, Lee YH, Shin SM. Treatment of PDA in premature newborns with mefenamic acid. Yeungnam University Journal of Medicine. 1993;10(2):506-11.
Park HJ, Jung YS, Kim NS, Kim CR, Kim H, Moon S. A Comparative Study of the Effects of Intravenous Indomethacin and Oral Mefenamic Acid in the Treatment of Premature Infants with Patent Ductus Arteriosus. J Korean Pediatr Soc. 2001;44:32-9.
Gedam DS, Verma M, Patil U, Gedam S. Effect of Distraction Technique During Immunization to Reduce Behaviour Response Score (FLACC) to Pain in Toddlers. J Nepal Paediatr Soc. 2013;33(1):25-30.
Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs. 1997;23(3):293-7.
Merkel S, Voepel-Lewis T, Malviya S. Pain assessment in infants and young children: the FLACC scalex. Am J Nurs. 2002;102(10):55-68.
Kennedy A, Basket M, Sheedy K. Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey. Pediatrics. 2011;127(1):92-9.